How can combining several nonspecific biomarkers improve disease detection?

In the field of translational medicine, the use of highly specific biomarkers is ideal for clinical diagnosis; however, such markers are rare, as many candidates are found across various disease states.

To overcome this limitation, researchers can employ biomarker pattern proteome analysis. By studying the expression profiles of hundreds of proteins in parallel, several relatively nonspecific biomarkers can be combined to create a more specific disease index. This approach allows for the analysis of complex protein mixtures and expression differences, which can then be processed using computational methods to superimpose multiple proteomic spectra. This technique effectively distinguishes between disease and disease-free states, providing a more precise diagnostic tool than any single nonspecific marker could offer on its own.1